BOOST-IC

Bringing Optimised COVID-19 vaccine Schedules To ImmunoCompromised populations (BOOST-IC): an adaptive randomised controlled clinical trial

[BOOST-IC @BOOSTICStudy]

#OpenAccess @BMC_series #Trials

#statstwitter looking for the details of how we’re analysing @BOOSTICStudy?

#BOOSTIC: Statistical elements and design, lead by @mdymock25 @drdavidwjg @j_h_mcmahon
@MonashUni @AlfredHealth

https://t.co/sLeeYiJ9ao

[BOOST-IC @BOOSTICStudy]

Pleased to announce the publication of the #BOOSTIC protocol paper, describing how we’re exploring the role of booster doses of COVID-19 vaccines in immunocompromised hosts!

https://t.co/n2ZmOVndDx

@drdavidwjg @j_h_mcmahon @OrlaMorris61218 @MonashUni @AlfredHealth @mdymock25

[Joshua Hill, MD @JoshuaHillMD]

In follow up to our first study https://t.co/PVbO0tvtWH, we report the final analysis from the @CIBMTR @BMTCTN study of early (<4 mo) vs late (4-12 mo) SARS-CoV-2 vaccination after #HCT and #CART in 466 participants. @ASTCT @DrMiguelPerales @JeffAuletta
https://t.co/ur1vMHt80N

[BOOST-IC @BOOSTICStudy]

🚨BOOST-IC enrolled its 300th participant today!🚨

Well done to all our collaborators and thank you to our participants. 🥳👏🏻🎉

@AlfredHealth @MonashUni @TSANZ_txsoc @ALLGtrials @nhmrc #MRFF @ASHMMedia

[BOOST-IC @BOOSTICStudy]

Great summary on Flu and other vaccines for winter from @peripatetical Thanks Allen! https://t.co/bRhRABGuAU Get your Flu and COVID-19 vaccines this year💉💉Winter's coming! 🌧️🌩️

[BOOST-IC @BOOSTICStudy]

285 participants enrolled in #BOOSTIC.

Don’t forget, you can keep up to date on enrollment and access information for consumers, HCWs and about our study design on the BOOST-IC website (https://t.co/NpTWBp9RVY)

[BOOST-IC @BOOSTICStudy]

Thanks for highlighting this @EricTopol need to watch BA.2.87.1 https://t.co/ZI0NEoMMVS

[Dr David Griffin 🦠🧫💉 @drdavidwjg]

274 people are currently participating in @BOOSTICStudy across 11 sites in Australia, trying to understand and fine tune #COVID19 vaccine boosting for immunocompromised people. With mounting evidence for benefit, will you or someone you know be next?

[BOOST-IC @BOOSTICStudy]

XBB.1.5 monovalent vaccine effectiveness against hospitalisation? 2 papers out in @TheLancetInfDis from @C_HHansen https://t.co/bR8Ut6RFFZ and @Eurosurveillanc from @hvwerkhoven https://t.co/iWM4aXIDgV 70-75% effectiveness in those > 60 yrs old. Get boosted!

[BOOST-IC @BOOSTICStudy]

Amazing day @BOOSTICStudy 👋👋 260 people enrolled!! Congratulations https://t.co/NpTWBpapLw What a team of investigators and participants @TSANZ_txsoc @ALLGtrials @ASHMMedia @MonashUni

[James McMahon @j_h_mcmahon]

Now hiring to a project officer role for the PROPHECY study. Large MRFF funded clinical and scientific collaboration studying COVID vaccine responses in high risk populations.@PROPHEC19

https://t.co/yhYeGD7pOy

https://t.co/nGeUHiDbWL

[Chief Health Officer, Victoria @VictorianCHO]

In recent weeks there has been a rapid increase in people with COVID in hospital. Learn how to protect those most at risk of severe disease.
https://t.co/o840rReWCZ

[BOOST-IC @BOOSTICStudy]

COVID-19 XBB.1.5 vaccines now being administered in @BOOSTICStudy 💉 Congrats to the first sites to achieve this @AlfredHealth @MonashHealth @pahospital 🙏 Amazing work from these sites and all sites enrolling 👏👏���

[BOOST-IC @BOOSTICStudy]

https://t.co/hKaGfDCqmO

[BOOST-IC @BOOSTICStudy]

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines https://t.co/29tKuejf4F

[James McMahon @j_h_mcmahon]

🥵 off the press!! New COVID vaccine recs from ATAGI. https://t.co/Fpbc7NrKor

[BOOST-IC @BOOSTICStudy]

Onwards and upwards for BOOST-IC. Huge thanks to all of our participants and sites 🙏. And now XBB.1.5 waiting in the wings....... 💉🧚

[BOOST-IC @BOOSTICStudy]

XBB.1.5 vaccines are getting approved. ARTG updates today for @pfizer XBB.1.5 monovalent https://t.co/sX82AdLf3V 😯💉

[BOOST-IC @BOOSTICStudy]

Remarkable to look at COVID booster recs in different countries ATM. Everyone > 5 years in the US with an updated vaccine from @CDCgov https://t.co/zoInsX5etl compared to all over 75 and adults with severe immunocompromise from ATAGI @healthgovau https://t.co/Eymv0pZS9C 😯💉

[BOOST-IC @BOOSTICStudy]

Congrats to @pahospital on the recruitment of their first participant to @BOOSTICStudy!👏

Great to have you on board in this important study.

[BOOST-IC @BOOSTICStudy]

Very excited to be welcoming @pahospital and the Haematology team to start recruitment for @BOOSTICStudy 👏 👏Thanks to @mollee_peter @ALLGtrials and the whole team!